
Aster DM Quality Care Reports Q1 Unaudited Financial Results; Revenue from Operations Stands at INR 725.73 Crores
Aster DM Quality Care Limited, formerly known as Aster DM Healthcare Limited, has released its Unaudited Financial Results for the first quarter ending June 30, 2026, covering both standalone and consolidated performance metrics. The company’s results reflect ongoing operations across healthcare services, with key figures detailed in the interim financial statements.The standalone results show total income reaching INR 764.76 crores for the quarter ended June 30, 2026. This was derived from revenue from operations of INR 725.73 crores and other income of INR 39.03 crores. Total expenses for the period were recorded at INR 644.08 crores, resulting in a profit before tax of INR 10.89 crores. After deducting total tax expense of INR 25.19 crores, the company reported a loss of INR 14.30 crores for the quarter.
The Unaudited Standalone Financial Results present operational performance across various metrics, as detailed in the table below:
| Particulars | Quarter ended 30 June 2026 (Unaudited) | Quarter ended 31 March 2026 (Unaudited) | Quarter ended 30 June 2025 (Unaudited) | Year ended 31 March 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 725.73 | 655.10 | 613.04 | 2,615.70 |
| Total income | 764.76 | 695.65 | 651.47 | 2,770.73 |
| Total expenses | 644.08 | 575.28 | 539.05 | 2,306.61 |
| Profit before tax | 10.89 | 42.64 | 108.03 | 374.20 |
| Profit/(Loss) for the period | (14.30) | 27.46 | 80.59 | 267.82 |
Key Operational and Investment Activities
During the quarter, several strategic investments and expenses were noted in the company's operations:- Merger-related Expenses: A significant expense amounting to INR 109.79 crores was incurred toward professional fees and other costs related to the merger, which was presented as an Exceptional Item.
- Subsidiary Stake Acquisition: The Company acquired an additional 1.54% stake in its subsidiary Malabar Institute of Medical Sciences Limited from several minority shareholders for INR 31.40 crores. This increased the company's shareholding in the institute from 79.75% as of March 31, 2026, to 81.29% as of June 30, 2026.
- Additional Investments: The Company made an additional investment of INR 45.09 crores in equity shares in Aster DM-Super Specialty Hospital (Sarjapur) Private Limited, a wholly owned subsidiary, and an investment of INR 25.00 crores in Optionally Convertible Redeemable Preference Shares (OCRPS) in Alfaone Medicals Private Limited, an associate.
Consolidated Financial Overview
Regarding the Unaudited Consolidated Financial Results, which include financial information from 16 subsidiaries and the ESOP trust, the results reflect the contribution of associates. The Group’s share of net profit after tax stood at INR 0.15 crores, with total comprehensive income reported at INR 0.15 crores for the quarter ended June 30, 2026, in respect of two associates based on their interim financial information.The results were prepared in accordance with Ind AS 34 'Interim Financial Reporting', which is prescribed under Section 133 of the Companies Act, 2013, read with relevant rules thereunder.
ASTERDM Stock Price Movement
Shares of Aster DM Quality Care Limited slipped today, closing at ₹842.1 after a minor decline of 0.20%. The stock saw active trading, with nearly 1.2 million shares transacted as the equity moved within its daily range, testing lows near ₹825.65 and highs up to ₹856.75.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.